The Beauty Health Company (SKIN) Misses Q4 EPS by 10c, Revenue Beats, Offers Guidance

The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.12), $0.10 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $71.1 million.

GUIDANCE:

The Beauty Health Company sees 2022 revenue of $320-330 million, versus the consensus of $314 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• Lucid reports Q2 output, names new CFO and five other leaders
• Goldman's Garrett sees investors dialing back tech exposure into H2
• Rivian raises 2026 delivery outlook after Q2 results top guidance